Koyfin Home > Directory > Health Care > Amphastar Pharma > Net Income

Amphastar Pharma Net Income Chart (AMPH)

Amphastar Pharma annual/quarterly Net Income from 2014 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
  • Amphastar Pharma Net Income for the last 12 months ending December 12, 2018 was $-6m a 36.72% decrease of -2m year over year
  • Amphastar Pharma Annual Net Income for 2018 was $-6m a 178.56% decrease of -10m from 2017
  • Amphastar Pharma Annual Net Income for 2017 was $5m a -133.63% decrease of -6m from 2016
  • Amphastar Pharma Annual Net Income for 2016 was $11m a 126.46% increase of 13m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Net Income Data

12/2018$2m
09/2018$2m
06/2018$-3m
03/2018$-7m
12/2017$1m
09/2017$0m
06/2017$2m
03/2017$1m
12/2016$-3m
09/2016$4m

Annual AMPH Net Income Data

2018$-6m
2017$5m
2016$11m
2015$-3m
2014$-11m
2013$12m